How the Active Truly Arrives
The Group's technology is not only about possessing ingredients, but about letting ingredients act — this is the oldest and the most contemporary problem of formulation science.
"Possessing an active is easy. Letting it truly act inside the skin — that is the hard part."
The physicochemical barriers to transdermal absorption are the daily problems of the formulator — molecular weight, polarity, partition coefficient. Any deviation, and the active becomes a promise that stays outside the stratum corneum.
Stability and activity are the eternal trade-off of formulation science. The more potent the ingredient, the more fragile; the more stable, the duller. Delivery systems exist to break this trade-off — letting activity and stability coexist.
Three Proprietary Delivery Architectures
Ultra-Nano Hyaluronic Dual-Delivery
Molecular weight gradient · Dual-phase release
Large molecules form a film at the surface and lock in water; small molecules cross the stratum corneum into the dermis — two scales, one arrival. The Group's proprietary delivery technology resolves the physical limit of traditional hyaluronic acid, which "only floats on the surface."
Multi-Peptide Synergistic Delivery
Liposomal encapsulation · Sequenced release
A single signal peptide easily loses activity in the formulation; combinations of multiple peptides demand even greater carrier protection. The Group's patented sustained-release technology releases the peptides on a timed sequence within the skin, preserving the full rhythm of the signaling cascade.
Ceramide Bilayer-Mimetic Delivery
Lipid bilayer · Biomimetic insertion
Mimicking the skin's native bilayer lipid structure, allowing exogenous ceramide to truly "embed" into the skin barrier — rather than staying on the surface. Barrier repair begins from biomimicry.
Active validation · Formulation prototype
Process scaling · Stability stress testing
Full-process quality control · Batch-to-batch consistency
Each transition between stages involves the engineering validation of formulation stability — the Group's GMP factory full-process quality control ensures that the promises of the laboratory still hold on the production line.
Co-formulation (II-3) addresses "how multiple actives coexist"; room-temperature stability technology addresses "how an active does not decay across shelf life" — two perspectives, the same patience.
The Group's room-temperature stability testing cycle far exceeds industry baselines. Every single product reaching the consumer's hand has been validated, before leaving the factory, under multiple scenarios of accelerated aging, cyclical temperature variation, and light stress.
This is another restraint of formulation science — not that it cannot be stronger, but that it must not be less stable.